Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.
The Global Advanced Drug Delivery Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $340 billion by 2025. Some of the prominent trends that the market is witnessing include growing focus on unmet medical requirements, increasing demand for generic drugs and biosimilars, rising familiarities of chronic diseases and recent technological developments of advanced drug delivery.
Based on technology, the market is categorized into polymeric drug delivery, implants & IUD's, sustained release, targeted drug delivery and prodrugs. By polymeric drug delivery, the market is further divided into nebulizers, metered dose inhalers and dry powder inhalers.
By end user, the market is segregated into hospitals, diagnostic centers, ambulatory surgical centers/clinics, home care settings and other end users.
The global Advanced Drug Delivery market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Advanced Drug Delivery market based on company, product type, end user and key regions.
This report studies the global market size of Advanced Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Advanced Drug Delivery in these regions.
This research report categorizes the global Advanced Drug Delivery market by top players/brands, region, type and end user. This report also studies the global Advanced Drug Delivery market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck & Co
F. Hoffmann-La Roche
Johnson & Johnson
Market size by Product
Polymeric Drug Delivery
Implants & IUD's
Targeted Drug Delivery
Market size by End User
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Advanced Drug Delivery market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Advanced Drug Delivery market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Advanced Drug Delivery companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Advanced Drug Delivery submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Advanced Drug Delivery are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Advanced Drug Delivery market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.